ABSTRACT The effects of mitral valve disease on lung function have been studied in 26 nonsmoking patients by relating values for lung volumes and carbon monoxide transfer factor (TLCO) to various indices of cardiac function measured at catheterisation. In general, more severe mitral disease was associated with greater abnormalities of lung function. Reductions of the one-second forced expiratory volume, vital capacity, TLCO and transfer coefficient, and increase in residual volume were all significantly related to the severity of mitral valve disease. In addition, the cardiothoracic ratio, measured radiographically, showed an inverse correlation with both vital capacity and total lung capacity. Although some of the consequences of mitral valve disease on lung function resemble those of primary airway disease, useful distinguishing points are the relative normality of the forced expiratory ratio and the absence of an increase in total lung capacity.
Abnormalities of lung mechanics and gas transfer are well recognised in initral valve disease but interpretation of the results of routine lung function tests in an individual patient is often difficult since the findings are not specific. The degree of abnormality in the results of simple tests that can result from mitral disease alone remains unclear, and most studies have taken no account of cigarette smoking. Attempts to correlate the severity of the valve disease with quantitative changes in lung function have produced variable results. Although relationships have been shown 1 2 between lung function and severity of dyspnoea, this does not necessarily give information about the cardiac contribution since both could reflect airways obstruction due to smoking. The only way to quantitate the effects of mitral disease per se would be to exclude patients with primary respiratory disease; but since chronic cough, sputum, and wheezing are often attributed to mitral disease patients cannot be excluded on symptomatic grounds alone. We have therefore identified a group of patients with mitral disease who have no history of previous respiratory disease and who are effectively nonsmokers, firstly, to assess the quantitative effects of mitral disease alone on the results of routine tests of lung function and, secondly, to examine the correlations between various indices of mitral valve function *Present address: Western Hospital, Southampton.
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Methods
Of a total of 72 consecutive patients with mitral valve disease undergoing cardiac catheterisation in the regional cardiothoracic centre, 26 were effectively nonsmokers and their results are described here (three of the 26 were ex-smokers but had smoked less than a total of five pack-years). Their ages ranged from 23 to 63. The patients comprised 20 with dominant mitral stenosis (nine of whom also had significant mitral regurgitation) and six with dominant mitral regurgitation (three of whom also had some stenosis), classified by the findings at cairdiac catheterisation. Three patients had significant aortic regurgitation in addition to the mitral lesions. No patient had heart failure on clinical criteria at the time of study but one showed septal lines on the chest radiograph. None had evidence of primary lung disease as assessed from the history and chest radiograph.
Respiratory symptoms were recorded. All except one had dyspnoea less than grade 3 (short of breath while walking at own pace on the flat). Heart TLCO showed significant correlations with cardiac index and valve area and inverse correlations with wedge pressure and vascular resistance. Kco showed significant inverse correlations with the valve gradient and wedge pressure.
Since there were clear relationships both within the pulmonary function indices and within the haemodynamic variables, multiple stepwise regressions were also performed. For each of the indices of lung function these showed that, once the effect of the best correlated haemodynamic variable had been accounted for, there were no significant relationships with the remaining variables. Cardio thoracic ratio (%) Relationship between vital capacity and cardiothoracic ratio in 26 non-smoking patients with mitral valve disease. consistent. Most of our patients were women but there is no reason to assume that the conclusions would not apply equally to men.
Previous studies have shown conflicting results when relating indices of lung function to those of cardiac disease but most have included smokers and some of the abnormalities of lung function could have been a consequence of cigarette-related disease rather than rheumatic heart disease alone. Some studies'28 have shown that those patients with the worst symptoms had the most abnormal lung function. Our study showed a similar trend but as most patients had a similar and moderate degree of dyspnoea we could not form any firm conclusions. Previous studies of the quantitative relationships between lung function and haemodynamic data are few and contradictory: negative correlations between vital capacity and pulmonary vascular resistance or mean pulmonary artery pressure have been reported9 10 but other studies" 12 have found no relationships. We confirmed a significant relationship between vital capacity and pulmonary vascular resistance. The present study shows that both FEV1 and vital capacity correlated best with the same indices of cardiac function -namely, pulmonary vascular resistance, cardiac output, and valve area. Since the FEV,/VC ratio was normal in most patients the correlations with FEV, largely follow from those with vital capacity. There was, however, a weak negative correlation of the ratio with the gradient across the mitral valve. On simple spirometric criteria therefore airflow obstruction was rarely a major feature in non-smoking patients with mitral valve disease, and this agrees with the findings in some other studies.2 Palmer et al' suggested that airways obstruction may play an important part, but their study included smokers. We did not study patients with severe breathlessness and airways obstruction might be more prominent in the later stages. Eleven patients admitted to wheezing episodes; although the non-wheezers had a higher A 753 . * * . 00 group.bmj.com on June 16, 2017 -Published by http://thorax.bmj.com/ Downloaded from mean FEV,/VC ratio the difference was not statistically significant. The highly significant inverse relationship between cardiothoracic ratio and vital capacity suggests that some of the fall in vital capacity may be directly due to increased heart size in addition to the effects of vascular congestion.
The mean value of total lung capacity in our patients was normal (107 % predicted), which agrees with other studies, and it showed no correlation with the severity of the valve disease. An increase in residual volume in mitral disease has been observed in many studies21013 and attributed to a reduction in lung recoil at small lung volumes. 14 The present study confirmed that the increase in residual volume is correlated with the severity of the valve disease as assessed by the pulmonary artery pressure, wedge pressure, and mitral valve gradient.
The reduction of TLCO shown by our patients agrees with the findings of most other studies;1 15-9 but when simple correlations with haemodynamic data were sought in two previous studies'620 none were found. Some studies of mitral stenosis have suggested that the pulmonary capillary blood volume is high in the early stages of the disease, which leads to a rise in TLCO at this stage.' 16172021 Our patients showed a fall in TLCO with increasing severity of valve disease and we did not observe any early rise. The reduction in TLCO may result in part from maldistribution of ventilation. Account is taken of this by expressing TLCO per litre of ventilated lung (that is, as the Kco), and this was on average less reduced than the total TLCO (table 2) . Nevertheless, the Kco did show significant correlations with wedge pressure and mitral gradient, indicating that maldistribution of ventilation was only a partial explanation for the reduced TLco and, even in normally ventilated lung units, the rate of carbon monoxide uptake was inversely related to the severity of the mitral disease.
At a practical level in an individual patient with mitral valve disease clinicians are often faced with the question of how to distinguish between the functional consequences of primary respiratory disease and those of the cardiac disease. Patients with chronic airflow obstruction caused by cigarette smoking also show a raised residual volume and low TLCO; but the present study suggests that as consequences of mitral valve disease per se (1) chronic cough and sputum production are infrequent; (2) although episodic wheezing is fairly common, the FEV,/VC ratio is usually normal; (3) the total lung capacity (measured by plethysmography) tends to be normal, whereas in primary airway disease it is usually increased.
